Literature DB >> 8110953

Intraabdominal infections.

S L Gorbach1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8110953     DOI: 10.1093/clinids/17.6.961

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Management of secondary peritonitis.

Authors:  D H Wittmann; M Schein; R E Condon
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

2.  Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections.

Authors:  J A Passarell; A K Meagher; K Liolios; B B Cirincione; S A Van Wart; T Babinchak; E J Ellis-Grosse; P G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 3.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

4.  Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  J-H Lee; J-H Yoon; B H Kim; G E Chung; S J Myung; W Kim; Y J Kim; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

5.  Ciprofloxacin vs. cefotaxime regimens for the treatment of intra-abdominal infections.

Authors:  J A Hoogkamp-Korstanje
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

6.  A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].

Authors:  María E Oliva; Arcot Rekha; Albert Yellin; Jacyr Pasternak; Maria Campos; Gilbert M Rose; Timothy Babinchak; Evelyn J Ellis-Grosse; Evan Loh
Journal:  BMC Infect Dis       Date:  2005-10-19       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.